Vacis Tatarunas
Overview
Explore the profile of Vacis Tatarunas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aldujeli A, Patel R, Grabauskyte I, Hamadeh A, Lieponyte A, Tatarunas V, et al.
J Cardiovasc Dev Dis
. 2023 May;
10(5).
PMID: 37233164
Introduction: Persistent coronary microcirculatory dysfunction (CMD) and elevated trimethylamine N-oxide (TMAO) levels after ST-elevation myocardial infarction (STEMI) may drive negative structural and electrical cardiac remodeling, resulting in new-onset atrial fibrillation...
12.
Aldujeli A, Haq A, Tecson K, Kurnickaite Z, Lickunas K, Bailey S, et al.
Crit Care
. 2022 Dec;
26(1):393.
PMID: 36539907
Background: Epinephrine is routinely utilized in cardiac arrest; however, it is unclear if the route of administration affects outcomes in acute myocardial infarction patients with cardiac arrest. Objectives: To compare...
13.
Matuleviciute I, Sidaraite A, Tatarunas V, Veikutiene A, Dobiliene O, Zaliuniene D
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010366
. Optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) allowed visualization of retina and choroid to nearly the capillary level; however, the relationship between systemic macrovascular status and...
14.
Meskauskaite U, Andruskeviciute S, ciapiene I, Giedraitiene A, Lesauskaite V, Tatarunas V
Drug Des Devel Ther
. 2022 Aug;
16:2559-2568.
PMID: 35959420
Background: Antiplatelet drugs, such as ticagrelor, which target platelet P2Y receptors, are used for prevention of ischemic heart disease. Ticagrelor is also known to have pleiotropic effects of unknown mechanisms....
15.
Stakisaitis D, Kapocius L, Valanciute A, Balnyte I, Tamosuitis T, Vaitkevicius A, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625699
Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and...
16.
Giedraitiene A, Pereckaite L, Bredelyte-Gruodiene E, Virgailis M, ciapiene I, Tatarunas V
Future Microbiol
. 2022 May;
17:789-802.
PMID: 35549350
ESBL-producing and bacterial biofilms-forming are associated with antimicrobial treatment failure. This study aimed to investigate the phenotypic resistance mechanisms of CTX-M against old antibiotics - cell wall synthesis inhibitors temocillin,...
17.
Tatarunas V, Aldujeli A, Kurnickaite Z, Maciulevicius L, Burkanas M, Venius J, et al.
Per Med
. 2022 Feb;
19(3):207-217.
PMID: 35172619
The goals of this study were to develop a new technique that could pave the way for a quicker determination of rs3093135 and rs4244285 variants directly from a patient's blood...
18.
Jurgeleviciene I, Stanislovaitiene D, Tatarunas V, Jurgelevicius M, Zaliuniene D
Medicina (Kaunas)
. 2020 Dec;
56(12).
PMID: 33260342
Glycation occurs in a variety of human tissues and organs. Knowledge about the relationship between predictive biochemical factors such as absorption of glycated nail proteins and severity of type 2...
19.
Tatarunas V, Kupstyte-Kristapone N, Zvikas V, Jakstas V, Zaliunas R, Lesauskaite V
Sci Rep
. 2020 Feb;
10(1):3175.
PMID: 32081968
Antiplatelet drugs are prescribed without considering the diabetic status of the patient. The objective of the current investigation was to determine the impact of clinical factors, CYP4F2 enzyme and 20-hydroxyeicosatetraenoic...
20.
Gecys D, Tatarunas V, Veikutiene A, Lesauskaite V
Biomarkers
. 2019 Nov;
25(1):40-47.
PMID: 31694408
To find an association of relative expression of hsa-miR-24-3p and hsa-miR-34a-5p molecules and CYP4F2 enzyme activity in blood plasma of stable angina pectoris (AP) patients'. MiRNA gene expression analysis was...